As I keep saying, I've looked for negatives for 2.5 years straight....
Not saying there haven't been any scares...not saying I haven't had a worry in all that time...
Not also saying we are 100% risk free going forwards....but I am saying that I like this story. I haven't seen anything like it and specially so early in the piece...we are so early in the story though so much has happened and we find ourselves in a P3.
I like what the patients are experiencing, though it doesn't work for 100% of patients.
The sheer number of potential future applications is actually mind-blowing. Just to be able to treat pain safely is compelling in itself. (Not just OA pain!)
DMOAD is quite another thing itself. First time possible regression of the OA disease, even if it is only in a fraction of the OA population.
research reports and media, page-3195
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.0¢ | 26.0¢ | $47.56K | 182.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 160460 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 17777 | 8 |
View Market Depth
| Last trade - 10.28am 30/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |